ALLOVIR INC (ALVR) Forecast, Price Target & Analyst Ratings
NASDAQ:ALVR • US0198181036
9.81 USD
+0.15 (+1.55%)
Last: Mar 18, 2025, 08:21 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ALLOVIR INC (ALVR).
Forecast Snapshot
Consensus Price Target
N/A
N/A
Next Earnings Forecast
Release DateMay 12, 2025
PeriodQ4 / 2025
EPS Estimate-$0.18
Revenue Estimate
ChartMill Buy Consensus
43.33%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $9.81 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
ALVR was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ALVR.
In the previous month the buy percentage consensus was at a similar level.
ALVR was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-12-26 | B of A Securities | Downgrade | Buy -> Underperform |
| 2023-12-22 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2023-12-22 | JP Morgan | Downgrade | Overweight -> Underweight |
| 2023-12-22 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2023-08-18 | B of A Securities | Initiate | Buy |
| 2023-08-07 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-04-26 | SVB Securities | Maintains | Outperform |
| 2023-01-27 | Morgan Stanley | Maintains | Overweight |
| 2023-01-23 | SVB Leerink | Maintains | Outperform |
| 2022-11-07 | SVB Leerink | Maintains | Outperform |
| 2022-09-09 | Morgan Stanley | Maintains | Overweight |
| 2022-07-28 | SVB Leerink | Maintains | Outperform |
| 2022-05-19 | Piper Sandler | Maintains | Overweight |
| 2022-02-10 | SVB Leerink | Maintains | Outperform |
| 2022-02-01 | BMO Capital | Initiate | Outperform |
| 2022-01-18 | Morgan Stanley | Maintains | Overweight |
| 2021-12-17 | SVB Leerink | Maintains | Outperform |
| 2021-11-08 | SVB Leerink | Maintains | Outperform |
| 2021-10-12 | Morgan Stanley | Maintains | Overweight |
| 2021-09-29 | Morgan Stanley | Maintains | Overweight |
| 2021-08-18 | Morgan Stanley | Maintains | Overweight |
| 2021-05-06 | SVB Leerink | Maintains | Outperform |
| 2021-04-19 | Morgan Stanley | Maintains | Overweight |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 12, 2025
PeriodQ4 / 2025
EPS Estimate-$0.18
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q-145.47%
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
ALVR is expected to report earnings on 5/12/2025. The consensus EPS estimate for the next earnings is -0.18 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.14M | 170K -85.09% | -100.00% | 390.15K | ||||||||||
| EBITDA YoY % growth | -3.6M | -26.68M -641.11% | -73.44M -167.02% | -166.26M -138.11% | -176.978M -0.50% | -192.667M -6.13% | -70.115M 61.25% | -55.995M 20.14% | -62.525M -11.66% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -3.6M | -26.7M -641.67% | -75.066M -167.08% | -169.409M -138.14% | -184.517M -0.81% | -189.785M -5.92% | -65.032M 64.14% | -39.673M 38.99% | -73.72M -85.82% | -57.8M 21.59% | -58.378M -1.00% | -58.962M -1.00% | -59.552M -1.00% | |
| Operating Margin | -315.79% | -15,705.88% | N/A | -43,421.52% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -105.96 | -61.86 97.41% | -52.71 17.88% | -40.96 25.78% | -0.51 69.66% | -0.30 41.61% | -0.45 -51.72% | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -0.18 -145.47% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
20.08%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
18.66%
EBIT Next 5 Year
N/A
ALLOVIR INC / ALVR Forecast FAQ
What is the next earnings date for ALVR stock?
ALLOVIR INC (ALVR) will report earnings on 2025-05-12.
What are the consensus estimates for ALLOVIR INC (ALVR) next earnings?
The consensus EPS estimate for the next earnings of ALLOVIR INC (ALVR) is -0.18 USD and the consensus revenue estimate is 0 USD.